Tristan P.
- Country
- France
- Department
- Service de Rhumatologie
Research Overview
- Investigation of LEO 158968 on Pharmacokinetics, Safety, and Tolerability in Patients with Gout Flares
- Comparison of Bimekizumab versus Adalimumab for the Treatment of Anterior Chest Wall Pain in Patients with Active Axial Spondyloarthritis Refractory to NSAIDs
- Efficacy of a sequential treatment strategy in Rheumatoid Arthritis. A randomized controlled trial with an independent efficacy assessor.
Data & Insights
Has run more than one trial at 42 of 139 partner sites.
Specializations
Rheumatoid Arthritis Management
The investigator specializes in developing innovative approaches for rheumatoid arthritis treatment, with particular focus on targeted therapies and treatment optimization strategies.
- JAK inhibitor dose optimization
- Combination therapy assessment
- Biological drug tapering strategies
Research extends to comparing different therapeutic agents including tocilizumab, abatacept, and baricitinib for optimal patient outcomes.
Gout Treatment Innovation
The investigator conducts extensive research in gout management, focusing on both acute flare treatment and long-term therapeutic approaches.
- Novel therapeutic compounds evaluation
- Treatment strategies for complex cases
- Urate-lowering therapy optimization
Special attention is given to hyperuricemia management and treatment approaches for patients with chronic kidney disease.
Osteoarthritis Research
The investigator explores innovative treatments for knee osteoarthritis, focusing on pain management and disease modification.
- Novel therapeutic agents assessment
- Pain management strategies
- Subcutaneous treatment approaches
Research includes evaluation of new compounds for improving patient outcomes in degenerative joint disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.